{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:04:58Z","timestamp":1778501098571,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:00:00Z","timestamp":1544400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Fund Flanders (FWO","doi-asserted-by":"publisher","award":["G051812N"],"award-info":[{"award-number":["G051812N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Fund Flanders (FWO","doi-asserted-by":"publisher","award":["12I0317N"],"award-info":[{"award-number":["12I0317N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"University of Antwerp","doi-asserted-by":"publisher","award":["TT-ZAPBOF 33049"],"award-info":[{"award-number":["TT-ZAPBOF 33049"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"University of Antwerp","doi-asserted-by":"publisher","award":["DOCPRO4 33265"],"award-info":[{"award-number":["DOCPRO4 33265"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijpddr.2018.12.001","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T04:02:47Z","timestamp":1544500967000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure"],"prefix":"10.1016","volume":"9","author":[{"given":"S.","family":"Hendrickx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bult\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Van den Kerkhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4361-8911","authenticated-orcid":false,"given":"P.","family":"Cos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3972-616X","authenticated-orcid":false,"given":"P.","family":"Delputte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-3202","authenticated-orcid":false,"given":"G.","family":"Caljon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2018.12.001_bib1","doi-asserted-by":"crossref","first-page":"e1657","DOI":"10.1371\/journal.pntd.0001657","article-title":"Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis","volume":"6","author":"Bhandari","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"Leishmania resistance to miltefosine associated with genetic marker","volume":"18","author":"Cojean","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF00931658","article-title":"Cyclophosphamide affects the dynamics of granuloma formation in experimental visceral leishmaniasis","volume":"78","author":"Correa","year":"1992","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005641","article-title":"Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress","volume":"11","author":"Deep","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib5","first-page":"664","article-title":"Kala-azar elimination programme in India","volume":"106","author":"Dhillon","year":"2008","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib6","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib1a","article-title":"Miltefosine enhances the fitness of a non-virulent drug-resistant Leishmania infantum strain","author":"Eberhardt","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijpddr.2018.12.001_bib7","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1093\/jac\/dks273","article-title":"Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis","volume":"67","author":"Fortin","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1590\/S0037-86822012000100006","article-title":"Clinical and laboratory alterations in dogs naturally infected by Leishmania chagasi","volume":"45","author":"Freitas","year":"2012","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib9","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00436-014-3835-7","article-title":"Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum","volume":"113","author":"Hendrickx","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib10","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/AAC.00707-15","article-title":"In vivo selection of paromomycin and miltefosine resistance in Leishmania donovani and L. Infantum in a Syrian hamster model","volume":"59","author":"Hendrickx","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib11","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00436-015-4460-9","article-title":"Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum","volume":"114","author":"Hendrickx","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/pim.12316","article-title":"In vivo characterization of two additional Leishmania donovani strains using the murine and hamster model","volume":"38","author":"Kauffmann","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.4449","article-title":"HIV and the spectrum of human disease","volume":"235","author":"Lucas","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154101","article-title":"Genomic and molecular characterization of miltefosine resistance in Leishmania infantum strains with either natural or acquired resistance through experimental selection of intracellular amastigotes","volume":"11","author":"Mondelaers","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2018.12.001_bib15","first-page":"32","article-title":"Treatment options for visceral leishmaniasis and HIV coinfection","volume":"18","author":"Monge-Maillo","year":"2016","journal-title":"AIDS Rev."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003021","article-title":"Visceral leishmaniasis and HIV coinfection in the Mediterranean region","volume":"8","author":"Monge-Maillo","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003021","article-title":"Visceral leishmaniasis and HIV coinfection in the mediterranean region","volume":"8","author":"Monge-Maillo","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13071-016-1464-y","article-title":"Clinical, hematological and biochemical alterations in hamster (Mesocricetus auratus) experimentally infected with Leishmania infantum through different routes of inoculation","volume":"9","author":"Moreira","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2018.12.001_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/315268","article-title":"Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms","volume":"181","author":"Murray","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ijpddr.2018.12.001_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tvjl.2014.09.002","article-title":"An update on the diagnosis and treatment of canine leishmaniosis caused by Leishmania infantum (syn. L. chagasi)","volume":"202","author":"Noli","year":"2014","journal-title":"Vet. J."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0001-706X(92)90081-8","article-title":"The rapid development of drug-resistance by Trypanosoma evansi in immunosuppressed mice","volume":"50","author":"Osman","year":"1992","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib22","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug","volume":"47","author":"Perez-Victoria","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 5","key":"10.1016\/j.ijpddr.2018.12.001_bib23","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/ajhp\/56.suppl_5.S9","article-title":"Neutrophil deficiency and dysfunction in HIV-infected patients","volume":"56","author":"Pitrak","year":"1999","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003212","article-title":"Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo","volume":"8","author":"Pyana Pati","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00611-13","article-title":"Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain","volume":"4","author":"Rai","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2018.12.001_bib26","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)","volume":"22","author":"Seifert","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2018.12.001_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","article-title":"Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo","volume":"30","author":"Seifert","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2018.12.001_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/08830185.2014.893301","article-title":"Neutropenia during HIV infection: adverse consequences and remedies","volume":"33","author":"Shi","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13071-017-1969-z","article-title":"Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India","volume":"10","author":"Srivastava","year":"2017","journal-title":"Parasit.Vectors"},{"key":"10.1016\/j.ijpddr.2018.12.001_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"van Griensven","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mimet.2017.06.003","article-title":"Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia","volume":"s139","author":"Vanhoutte","year":"2017","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.ijpddr.2018.12.001_bib33","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"Vermeersch","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.12.001_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.micres.2014.11.002","article-title":"Effects of cyclophosphamide on immune system and gut microbiota in mice","volume":"171","author":"Xu","year":"2015","journal-title":"Microbiol. Res."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221132071830160X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221132071830160X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:48:27Z","timestamp":1761922107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221132071830160X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":35,"alternative-id":["S221132071830160X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.12.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}